- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced NSCLC
Total 7279 results
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR Mutated NSCLC.Taiwan
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.Active, not recruitingLocally Advanced or Metastatic NSCLCChina
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingBreast Cancer | NSCLC | HNSCC | Locally Advanced or Metastatic Solid TumorsChina
-
Peking University Cancer Hospital & InstituteEnrolling by invitationLocally Advanced NSCLCChina
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland
-
University of CincinnatiNot yet recruitingCancer | Metastatic Cancer | Locally Advanced Solid Tumor | Locally Advanced | Locally Advanced CarcinomaUnited States
-
Sheba Medical CenterRambam Health Care Campus; AstraZeneca; Tel-Aviv Sourasky Medical CenterRecruitingMetastatic or Locally Advanced NSCLCIsrael
-
Mt. Sinai Medical Center, MiamiAmgenCompletedUnresectable Locally Advanced NSCLCUnited States
-
Palobiofarma SLOhio State UniversityActive, not recruiting
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedAdvanced Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
LetolabNot yet recruitingLocally Advanced or Metastatic CRC
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingLocally Advanced Solid TumorAustralia
-
Fudan UniversityNot yet recruitingNSCLC | Locally Advanced Lung CarcinomaChina
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | Advanced Solid Tumor | CRCUnited States
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingNSCLC | Advanced Solid TumorUnited States, China
-
Adlai Nortye Biopharma Co., Ltd.RecruitingLocally Advanced Solid TumorUnited States
-
OBI Pharma, IncTerminatedLocally Advanced Solid TumorUnited States
-
Suzhou Forlong Biotechnology Co.,Ltd,Active, not recruitingLocally Advanced/Metastatic Solid TumorsUnited States
-
BJ Bioscience, Inc.Merck Sharp & Dohme LLC; PPDActive, not recruitingLocally Advanced/Metastatic Solid TumorsUnited States
-
Merck Sharp & Dohme LLCCompletedLocally Advanced, Metastatic Solid Tumors
-
Merck Sharp & Dohme LLCCompletedMetastatic or Locally Advanced Cancer
-
Bio-Thera SolutionsRecruitingLocally Advanced/Metastatic Solid TumoursChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Malignant Solid NeoplasmUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Bladder Urothelial Carcinoma | Locally Advanced Renal Pelvis Urothelial... and other conditionsUnited States
-
Jun Zhang, MD, PhDRhode Island HospitalRecruitingNSCLC, Stage III | Locally Advanced Lung CarcinomaUnited States
-
German Cancer Research CenterRecruiting
-
University Medical Center GroningenActive, not recruiting
-
Shanghai HyaMab Biotech Co.,Ltd.CompletedLocally Advanced/Metastatic Solid TumorsUnited States
-
Shanghai HyaMab Biotech Co.,Ltd.CompletedLocally Advanced/Metastatic Solid TumorsChina
-
Merck KGaA, Darmstadt, GermanyCompletedLocally Advanced or Metastatic Solid TumorsHungary
-
National Cancer Institute (NCI)SuspendedLocally Advanced Leiomyosarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Locally Advanced Liposarcoma | Locally Advanced Undifferentiated Pleomorphic Sarcoma | Locally Advanced Extraskeletal Myxoid Chondrosarcoma | Locally Advanced Unresectable Soft Tissue SarcomaUnited States, Canada
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic Solid TumorsChina
-
Avistone Biotechnology Co., Ltd.Zhejiang Cancer Hospital; Henan Cancer Hospital; Hunan Cancer Hospital; Peking... and other collaboratorsRecruitingLocally Advanced or Metastatic Solid TumorsChina
-
TYK Medicines, IncRecruitingLocally Advanced or Metastatic Solid TumorsChina
-
Bio-Thera SolutionsRecruitingLocally Advanced or Metastatic Solid TumorsChina
-
Chugai PharmaceuticalRecruitingLocally Advanced or Metastatic Solid TumorsUnited States, Japan
-
Assiut UniversityNot yet recruitingLocally Advanced Cervical Carcinoma
-
Chugai PharmaceuticalRecruitingLocally Advanced or Metastatic Solid TumorsUnited States, Japan
-
Pierre Fabre MedicamentTerminatedLocally Advanced or Metastatic Solid TumorsFrance, Spain
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedLocally Advanced or Metastatic Solid TumorsUnited States, United Kingdom